Keywords

Cancer researchMEK inhibitorMAPK/ERK pathwayMelanomaKinaseSignal transductionMutationLung cancerTrametinibBiologySelumetinibBreast cancerCancerTargeted therapyMedicineGeneOncologyGenetics

Affiliated Institutions

Related Publications

Publication Info

Year
2005
Type
article
Volume
439
Issue
7074
Pages
358-362
Citations
1317
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1317
OpenAlex

Cite This

David B. Solit, Levi A. Garraway, Christine A. Pratilas et al. (2005). BRAF mutation predicts sensitivity to MEK inhibition. Nature , 439 (7074) , 358-362. https://doi.org/10.1038/nature04304

Identifiers

DOI
10.1038/nature04304